<!DOCTYPE html>
<html lang="en" dir="auto">

<head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script><meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>OrgSyn022 | OrgSyn</title>
<meta name="keywords" content="">
<meta name="description" content="本篇策略为1,5-2H-吡咯-2-酮的合成。原文：Org. Synth.  2023 ,  100 , 418-445.">
<meta name="author" content="Argon">
<link rel="canonical" href="//localhost:1313/posts/orgsyn022/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.css" rel="preload stylesheet" as="style">
<link rel="icon" href="//localhost:1313/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="//localhost:1313/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="//localhost:1313/favicon-32x32.png">
<link rel="apple-touch-icon" href="//localhost:1313/apple-touch-icon.png">
<link rel="mask-icon" href="//localhost:1313/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<link rel="alternate" hreflang="en" href="//localhost:1313/posts/orgsyn022/">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --code-block-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:url" content="//localhost:1313/posts/orgsyn022/">
  <meta property="og:site_name" content="OrgSyn">
  <meta property="og:title" content="OrgSyn022">
  <meta property="og:description" content="本篇策略为1,5-2H-吡咯-2-酮的合成。原文：Org. Synth. 2023 , 100 , 418-445.">
  <meta property="og:locale" content="en">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-03-03T12:22:10+08:00">
    <meta property="article:modified_time" content="2025-03-03T12:22:10+08:00">
      <meta property="og:image" content="//localhost:1313/%3Clink%20or%20path%20of%20image%20for%20opengraph,%20twitter-cards%3E">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:image" content="//localhost:1313/%3Clink%20or%20path%20of%20image%20for%20opengraph,%20twitter-cards%3E">
<meta name="twitter:title" content="OrgSyn022">
<meta name="twitter:description" content="本篇策略为1,5-2H-吡咯-2-酮的合成。原文：Org. Synth.  2023 ,  100 , 418-445.">


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position":  1 ,
      "name": "Posts",
      "item": "//localhost:1313/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "OrgSyn022",
      "item": "//localhost:1313/posts/orgsyn022/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "OrgSyn022",
  "name": "OrgSyn022",
  "description": "本篇策略为1,5-2H-吡咯-2-酮的合成。原文：Org. Synth. 2023 , 100 , 418-445.\n",
  "keywords": [
    
  ],
  "articleBody": "本篇策略为1,5-2H-吡咯-2-酮的合成。原文：Org. Synth. 2023 , 100 , 418-445.\n简述 步骤A用 DBU 作碱，将羧酸变为羧酸甲酯1。\n步骤B加入 H2N-Dmb 和己醛，发生 Mannich 反应关环，形成吡咯-2-酮衍生物2。\n最后步骤C中使用 TFA 脱去 -Dmb 保护。\n讨论 含氮杂环结构在大量天然产物如各种生物碱和生物分子前体中出现1，五元含氮杂环更是多见，如吲哚、吡咯、吡咯烷和琥珀酰亚胺类。实际上，在 U.S. FDA 提出的25种最常见的含氮杂环结构中，五元环占了13种2。\n相关的分子非常多，下面摘录一些代表性的例子，包括含五元杂环结构的药物和天然产物3 4 5 6 7：\n在2018年市售小分子药物 top 200 中，存在大量含五元含氮杂环结构，也在此列出部分8：\n在各种含氮杂环中，吡咯酮类结构也大量出现，因此也就随之产生了大量合成策略，如 Huisgen reaction, Asinger reaction, Groebke-Blackburn-Bienayme reaction 等等，多官能团取代吡咯-2-酮的合成也有相关报道9 10 11。\n在这些报导的方法中，许多方法是线性合成，部分多组分合成需要提前准备前体或者条件苛刻，这都是其不足之处。\n许多多组分合成方法都使用了亚胺作为合成中间体12 13，因为亚胺能够原位合成，为高效合成提供了一种模块化的思路14。\nGein 和合作者利用酰基的吸电子作用设计了多组分合成（见上图 equation 1），但是反应时间很长15；Dekker 和合作者也用该方法合成了多种吡咯酮类化合物16。\nYe et al. 的方法也是利用酰基完成反应（见上图 equation 2），和 Gein 的思路类似17；2019年，Chebanov 和合作者发展了使用丙酮酸代替酯类参与反应的方法（见上图 equation 3），该方法需要在异丙醇中回流18。\n还有其他的策略同样使用游离羧酸，如 Tye 和 Whittaker 的方法19，他们的方法需要回流以及超声波处理（见上图 equation 4）。\nJoo 和合作者以及 Yavari 和 Souri 同时独立地报导了类似的方法合成吡咯酮，Joo et al. 使用酸性条件和超声处理20（见上图 equation 5），而 Yavari 和 Souri 使用了高反应性的草酰氯21（见上图 equation 6）。\n作者团队建立了一种可以获得多取代吡咯-2,3-酮（见上图 equation 7），以及双环产物（见上图 equation 8）的策略22。且反应所需条件非常温和，可以用于构建相关药物分子或生物活性分子的复杂结构。\n参考 Taylor, R. D.; MacCoss, M.; Lawson, A. D. G. Rings in Drugs. J. Med. Chem. 2014, 57, 5845-5859. https://doi.org/10.1021/jm4017625. ↩︎\nVitaku, E.; Smith, D. T.; Njardarson, J. T. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J. Med. Chem. 2014, 57, 10257-10274. https://doi.org/10.1021/jm501100b. ↩︎\nNeuss, N.; Neuss, M. N. The Alkaloids: Chemistry and Pharmacology. Alkaloids Chem. Pharmacol. 1990, 37, 229-240. https://doi.org/10.1016/s0099-9598(08)60097-8. ↩︎\nCannon, J. S.; Overman, L. E. Is There No End to the Total Syntheses of Strychnine? Lessons Learned in Strategy and Tactics in Total Synthesis. Angew. Chem. Int. Ed. 2012, 51, 4288-4311. https://doi.org/10.1002/anie.201107385. ↩︎\nFeling, R. H.; Buchanan, G. O.; Mincer, T. J.; Kauffman, C. A.; Jensen, P. R.; Fenical, W. Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus Salinospora. Angew. Chem. Int. Ed. 2003, 42, 355-357. https://doi.org/10.1002/anie.200390115. ↩︎\nAsami, Y.; Kakeya, H.; Onose, R.; Yoshida, A.; Matsuzaki, H.; Osada, H. Azaspirene: A Novel Angiogenesis Inhibitor Containing a 1-Oxa-7-Azaspiro[4.4]Non-2-Ene-4,6-Dione Skeleton Produced by the Fungus Neosartorya Sp. Org. Lett. 2002, 4, 2845-2848. https://doi.org/10.1021/ol020104+. ↩︎\nFujiwara, R.; Haag, M.; Schaeffeler, E.; Nies, A. T.; Zanger, U. M.; Schwab, M. Systemic Regulation of Bilirubin Homeostasis: Potential Benefits of Hyperbilirubinemia. Hepatology 2018, 67, 1609-1619. https://doi.org/10.1002/hep.29599. ↩︎\nNjardarson, J. T. Top 200 Small Molecule Drugs by Sales in 2018; 2018. https://njardarson.lab.arizona.edu/content/top-pharmaceuticals-poster. ↩︎\nCaruano, J.; Muccioli, G. G.; Robiette, R. Biologically Active γ-Lactams: Synthesis and Natural Sources. Org. Biomol. Chem. 2016, 14, 10134-10156. https://doi.org/10.1039/c6ob01349j. ↩︎\nDömling, A.; Wang, W.; Wang, K. Chemistry and Biology Of Multicomponent Reactions. Chem. Rev. 2012, 112, 3083-3135. https://doi.org/10.1021/cr100233r. ↩︎\nZhi, S.; Ma, X.; Zhang, W. Consecutive Multicomponent Reactions for the Synthesis of Complex Molecules. Org. Biomol. Chem. 2019, 17, 7632-7650. https://doi.org/10.1039/c9ob00772e. ↩︎\nLayer, R. W. The Chemistry of Imines. Chem. Rev. 1963, 63, 489-510. https://doi.org/10.1021/cr60225a003. ↩︎\nLi, C.-J.; Trost, B. M. Green Chemistry for Chemical Synthesis. Proc. Natl. Acad. Sci. 2008, 105, 13197-13202. https://doi.org/10.1073/pnas.0804348105. ↩︎\nSun, A. W.; Lackner, S.; Stoltz, B. M. Modularity: Adding New Dimensions to Total Synthesis. Trends Chem. 2019. https://doi.org/10.1016/j.trechm.2019.05.008. ↩︎\n(a) Gein, V. L.; Kasimova, N. N.; Potemkin, K. D. Simple Three-Component Synthesis of 4-Acyl-1-(2-Aminoethyl)-5-Aryl-3-Hydroxy-2,5-Dihydropyrrol-2(1H)-Ones. Russ. J. Gen. Chem. 2002, 72, 1150-1151. https://doi.org/10.1023/a:1020783623210; (b) Gein, V. L.; Odegova, T. F.; Korol’, A. N.; Varkentin, L. I.; Bobyleva, A. A.; Gein, L. F.; Vakhrin, M. I. Synthesis and Antibacterial Activity of 5-Aryl-4-Acyl-3-Hydroxy-1-(2-Hydroxyethyl)-3-Pyrrolin-2-Ones. Pharm. Chem. J. 2014, 47, 536-538. https://doi.org/10.1007/s11094-014-0999-5; (c) Gein, V. L.; Vychegzhanina, V. N.; Levandovskaya, E. B.; Syropyatov, B. Y.; Vakhrin, M. I.; Voronina, E. V.; Danilova, N. V. Synthesis and Antibacterial and Analgesic Activity of 5-Aryl-4-Acyl-3-Hydroxy-1(2,2-Dimethoxyethyl)-3-Pyrrolin-2-Ones. Pharm. Chem. J. 2010, 44, 370-373. https://doi.org/10.1007/s11094-010-0470-1; (d) Gein, V. L.; Kasimova, N. N.; Voronina, É. V.; Gein, L. F. Synthesis and Antimicrobial Activity of 5-Aryl-4-Acyl-1-(N,N-Dimethylaminoethyl)-3-Hydroxy-3-Pyrrolin-2-Ones. Pharm. Chem. J. 2001, 35, 151-154. https://doi.org/10.1023/a:1010457912881; (e) Gein, V. L.; Buldakova, E. A.; Korol, A. N.; Veikhman, G. A.; Dmitriev, M. V. Synthesis of 5-Aryl-4-Aroyl-3-Hydroxy-1-Cyanomethyl-3-Pyrrolin-2-Ones. Russ. J. Gen. Chem. 2018, 88, 908-911. https://doi.org/10.1134/s1070363218050110; (f) Gein, V. L.; Kasimova, N. N.; Aliev, Z. G.; Vakhrin, M. I. Three-Component Reaction of Methyl 2,4-Dioxo-4-Phenylbutanoate and Methyl 2,4-Dioxopentanoate with Aromatic Aldehydes and Propane-1,2-Diamine and Chemical Properties of the Products. Russ. J. Org. Chem. 2010, 46, 875-883. https://doi.org/10.1134/s1070428010060163. ↩︎\nReddy, T. R. K.; Li, C.; Guo, X.; Myrvang, H. K.; Fischer, P. M.; Dekker, L. V. Design, Synthesis, and Structure-Activity Relationship Exploration of 1-Substituted 4-Aroyl-3-Hydroxy-5-Phenyl-1H-Pyrrol-2(5H)-One Analogues as Inhibitors of the Annexin A2-S100A10 Protein Interaction. J. Med. Chem. 2011, 54, 2080-2094. https://doi.org/10.1021/jm101212e. ↩︎\nMa, K.; Wang, P.; Fu, W.; Wan, X.; Zhou, L.; Chu, Y.; Ye, D. Rational Design of 2-Pyrrolinones as Inhibitors of HIV-1 Integrase. Bioorg. Med. Chem. Lett. 2011, 21, 6724-6727. https://doi.org/10.1016/j.bmcl.2011.09.054. ↩︎\n(a) Morozova, A. D.; Muravyova, E. A.; Shishkina, S. V.; Sysoiev, D.; Glasnov, T.; Musatov, V. I.; Desenko, S. M.; Chebanov, V. A. Features of 3-Amino-5-Methylisoxazole in Heterocyclizations Involving Pyruvic Acids. Chem. Heterocyc. Compd. 2019, 55, 78-89. https://doi.org/10.1007/s10593-019-02422-8; (b) Sakhno, Y. I.; Desenko, S. M.; Shishkina, S. V.; Shishkin, O. V.; Sysoyev, D. O.; Groth, U.; Kappe, C. O.; Chebanov, V. A. Multicomponent Cyclocondensation Reactions of Aminoazoles, Arylpyruvic Acids and Aldehydes with Controlled Chemoselectivity. Tetrahedron 2008, 64, 11041-11049. https://doi.org/10.1016/j.tet.2008.09.089; (c) Murlykina, M. V.; Sakhno, Y. I.; Desenko, S. M.; Shishkina, S. V.; Shishkin, O. V.; Sysoiev, D. O.; Kornet, M. N.; Schols, D.; Goeman, J. L.; Eycken, J. V. der; et al. Study of the Chemoselectivity of Multicomponent Heterocyclizations Involving 3-Amino-1,2,4-Triazole and Pyruvic Acids as Key Reagents, and Biological Activity of the Reaction Products. Eur. J. Org. Chem. 2015, 2015, 4481-4492. https://doi.org/10.1002/ejoc.201500469. ↩︎\nTye, H.; Whittaker, M. Use of a Design of Experiments Approach for the Optimisation of a Microwave Assisted Ugi Reaction. Org. Biomol. Chem. 2004, 2, 813. https://doi.org/10.1039/b400298a. ↩︎\nAhankar, H.; Ramazani, A.; Ślepokura, K.; Lis, T.; Joo, S. W. Synthesis of Pyrrolidinone Derivatives from Aniline, an Aldehyde and Diethyl Acetylenedicarboxylate in an Ethanolic Citric Acid Solution under Ultrasound Irradiation. Green Chem. 2016, 18, 3582-3593. https://doi.org/10.1039/c6gc00157b. ↩︎\nYavari, I.; Souri, S. Synthesis of Functionalized 5-Oxo-2,5-Dihydro-1 H -Pyrroles from Primary Alkylamines, Oxalyl Chloride, and Dimethyl Acetylenedicarboxylate. Synlett 2008, 2008, 1208-1210. https://doi.org/10.1055/s-2008-1072657. ↩︎\n(a) Cusumano, A. Q.; Pierce, J. G. 3-Hydroxy-1,5-Dihydro-2H-Pyrrol-2-Ones as Novel Antibacterial Scaffolds against Methicillin-Resistant Staphylococcus Aureus. Bioorg. Med. Chem. Lett. 2018, 28, 2732-2735. https://doi.org/10.1016/j.bmcl.2018.02.047; (b) Cusumano, A. Q.; Boudreau, M. W.; Pierce, J. G. Direct Access to Highly Functionalized Heterocycles through the Condensation of Cyclic Imines and α-Oxoesters. J. Org. Chem. 2017, 82, 13714-13721. https://doi.org/10.1021/acs.joc.7b02572; (c) Shymanska, N. V.; Pierce, J. G. Stereoselective Synthesis of Quaternary Pyrrolidine-2,3-Diones and β-Amino Acids. Org. Lett. 2017, 19, 2961-2964. https://doi.org/10.1021/acs.orglett.7b01185; (d) Massaro, N. P.; Pierce, J. G. Stereoselective, Multicomponent Approach to Quaternary Substituted Hydroindole Scaffolds. Org. Lett. 2020, 22, 5079-5084. https://doi.org/10.1021/acs.orglett.0c01650; (e) Massaro, N. P.; Pierce, J. G. Rapid synthesis of the core scaffold of crinane and haemanthamine through a multi-component approach. Tetrahedron Lett. 2021, 75, 153201. https://doi.org/10.1016/j.tetlet.2021.153201. ↩︎\n",
  "wordCount" : "1040",
  "inLanguage": "en",
  "image": "//localhost:1313/%3Clink%20or%20path%20of%20image%20for%20opengraph,%20twitter-cards%3E","datePublished": "2025-03-03T12:22:10+08:00",
  "dateModified": "2025-03-03T12:22:10+08:00",
  "author":{
    "@type": "Person",
    "name": "Argon"
  },
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "//localhost:1313/posts/orgsyn022/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "OrgSyn",
    "logo": {
      "@type": "ImageObject",
      "url": "//localhost:1313/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="//localhost:1313/" accesskey="h" title="OrgSyn (Alt + H)">
                <img src="//localhost:1313/apple-touch-icon.png" alt="" aria-label="logo"
                    height="35">OrgSyn</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
            <li>
                <a href="//localhost:1313/archives/" title="archive">
                    <span>archive</span>
                </a>
            </li>
            <li>
                <a href="//localhost:1313/about/" title="about">
                    <span>about</span>
                </a>
            </li>
            <li>
                <a href="//localhost:1313/search/" title="search (Alt &#43; /)" accesskey=/>
                    <span>search</span>
                </a>
            </li>
        </ul>
    </nav>
</header>
<main class="main">

<article class="post-single">
  <header class="post-header">
    <div class="breadcrumbs"><a href="//localhost:1313/">Home</a>&nbsp;»&nbsp;<a href="//localhost:1313/posts/">Posts</a></div>
    <h1 class="post-title entry-hint-parent">
      OrgSyn022
    </h1>
    <div class="post-meta"><span title='2025-03-03 12:22:10 +0800 CST'>March 3, 2025</span>&nbsp;·&nbsp;5 min&nbsp;·&nbsp;1040 words&nbsp;·&nbsp;Argon&nbsp;|&nbsp;<a href="https://github.com/%3cpath_to_repo%3e/content" rel="noopener noreferrer" target="_blank">Suggest Changes</a>

</div>
  </header> <div class="toc">
    <details >
        <summary accesskey="c" title="(Alt + C)">
            <span class="details">Table of Contents</span>
        </summary>

        <div class="inner"><nav id="TableOfContents">
  <ul>
    <li><a href="#简述">简述</a></li>
    <li><a href="#讨论">讨论</a></li>
    <li><a href="#参考">参考</a></li>
  </ul>
</nav>
        </div>
    </details>
</div>

  <div class="post-content"><p>本篇策略为1,5-2H-吡咯-2-酮的合成。原文：<em>Org. Synth.</em>  <strong>2023</strong> ,  <em>100</em> , 418-445.</p>
<h2 id="简述">简述<a hidden class="anchor" aria-hidden="true" href="#简述">#</a></h2>
<p><img alt="022-1" loading="lazy" src="https://img.z4a.net/images/2025/03/03/022-1.png"></p>
<p>步骤<strong>A</strong>用 DBU 作碱，将羧酸变为羧酸甲酯<strong>1</strong>。</p>
<p>步骤<strong>B</strong>加入 H2N-Dmb 和己醛，发生 Mannich 反应关环，形成吡咯-2-酮衍生物<strong>2</strong>。</p>
<p>最后步骤<strong>C</strong>中使用 TFA 脱去 -Dmb 保护。</p>
<h2 id="讨论">讨论<a hidden class="anchor" aria-hidden="true" href="#讨论">#</a></h2>
<p>含氮杂环结构在大量天然产物如各种生物碱和生物分子前体中出现<sup id="fnref:1"><a href="#fn:1" class="footnote-ref" role="doc-noteref">1</a></sup>，五元含氮杂环更是多见，如吲哚、吡咯、吡咯烷和琥珀酰亚胺类。实际上，在 U.S. FDA 提出的25种最常见的含氮杂环结构中，五元环占了13种<sup id="fnref:2"><a href="#fn:2" class="footnote-ref" role="doc-noteref">2</a></sup>。</p>
<p>相关的分子非常多，下面摘录一些代表性的例子，包括含五元杂环结构的药物和天然产物<sup id="fnref:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup> <sup id="fnref:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup> <sup id="fnref:5"><a href="#fn:5" class="footnote-ref" role="doc-noteref">5</a></sup> <sup id="fnref:6"><a href="#fn:6" class="footnote-ref" role="doc-noteref">6</a></sup> <sup id="fnref:7"><a href="#fn:7" class="footnote-ref" role="doc-noteref">7</a></sup>：</p>
<p><img alt="022-2" loading="lazy" src="https://img.z4a.net/images/2025/03/03/022-2.png"></p>
<p>在2018年市售小分子药物 top 200 中，存在大量含五元含氮杂环结构，也在此列出部分<sup id="fnref:8"><a href="#fn:8" class="footnote-ref" role="doc-noteref">8</a></sup>：</p>
<p><img alt="022-3" loading="lazy" src="https://img.z4a.net/images/2025/03/03/022-3.png"></p>
<p>在各种含氮杂环中，吡咯酮类结构也大量出现，因此也就随之产生了大量合成策略，如 Huisgen reaction, Asinger reaction, Groebke-Blackburn-Bienayme reaction 等等，多官能团取代吡咯-2-酮的合成也有相关报道<sup id="fnref:9"><a href="#fn:9" class="footnote-ref" role="doc-noteref">9</a></sup> <sup id="fnref:10"><a href="#fn:10" class="footnote-ref" role="doc-noteref">10</a></sup> <sup id="fnref:11"><a href="#fn:11" class="footnote-ref" role="doc-noteref">11</a></sup>。</p>
<p>在这些报导的方法中，许多方法是线性合成，部分多组分合成需要提前准备前体或者条件苛刻，这都是其不足之处。</p>
<p>许多多组分合成方法都使用了亚胺作为合成中间体<sup id="fnref:12"><a href="#fn:12" class="footnote-ref" role="doc-noteref">12</a></sup> <sup id="fnref:13"><a href="#fn:13" class="footnote-ref" role="doc-noteref">13</a></sup>，因为亚胺能够原位合成，为高效合成提供了一种模块化的思路<sup id="fnref:14"><a href="#fn:14" class="footnote-ref" role="doc-noteref">14</a></sup>。</p>
<p><img alt="022-4" loading="lazy" src="https://img.z4a.net/images/2025/03/03/022-4.png"></p>
<p>Gein 和合作者利用酰基的吸电子作用设计了多组分合成（见上图 equation 1），但是反应时间很长<sup id="fnref:15"><a href="#fn:15" class="footnote-ref" role="doc-noteref">15</a></sup>；Dekker 和合作者也用该方法合成了多种吡咯酮类化合物<sup id="fnref:16"><a href="#fn:16" class="footnote-ref" role="doc-noteref">16</a></sup>。</p>
<p>Ye et al. 的方法也是利用酰基完成反应（见上图 equation 2），和 Gein 的思路类似<sup id="fnref:17"><a href="#fn:17" class="footnote-ref" role="doc-noteref">17</a></sup>；2019年，Chebanov 和合作者发展了使用丙酮酸代替酯类参与反应的方法（见上图 equation 3），该方法需要在异丙醇中回流<sup id="fnref:18"><a href="#fn:18" class="footnote-ref" role="doc-noteref">18</a></sup>。</p>
<p>还有其他的策略同样使用游离羧酸，如 Tye 和 Whittaker 的方法<sup id="fnref:19"><a href="#fn:19" class="footnote-ref" role="doc-noteref">19</a></sup>，他们的方法需要回流以及超声波处理（见上图 equation 4）。</p>
<p>Joo 和合作者以及 Yavari 和 Souri 同时独立地报导了类似的方法合成吡咯酮，Joo et al. 使用酸性条件和超声处理<sup id="fnref:20"><a href="#fn:20" class="footnote-ref" role="doc-noteref">20</a></sup>（见上图 equation 5），而 Yavari 和 Souri 使用了高反应性的草酰氯<sup id="fnref:21"><a href="#fn:21" class="footnote-ref" role="doc-noteref">21</a></sup>（见上图 equation 6）。</p>
<p>作者团队建立了一种可以获得多取代吡咯-2,3-酮（见上图 equation 7），以及双环产物（见上图 equation 8）的策略<sup id="fnref:22"><a href="#fn:22" class="footnote-ref" role="doc-noteref">22</a></sup>。且反应所需条件非常温和，可以用于构建相关药物分子或生物活性分子的复杂结构。</p>
<h2 id="参考">参考<a hidden class="anchor" aria-hidden="true" href="#参考">#</a></h2>
<div class="footnotes" role="doc-endnotes">
<hr>
<ol>
<li id="fn:1">
<p>Taylor, R. D.; MacCoss, M.; Lawson, A. D. G. Rings in Drugs. J. Med. Chem. 2014, 57, 5845-5859. <a href="https://doi.org/10.1021/jm4017625">https://doi.org/10.1021/jm4017625</a>.&#160;<a href="#fnref:1" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:2">
<p>Vitaku, E.; Smith, D. T.; Njardarson, J. T. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals. J. Med. Chem. 2014, 57, 10257-10274. <a href="https://doi.org/10.1021/jm501100b">https://doi.org/10.1021/jm501100b</a>.&#160;<a href="#fnref:2" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:3">
<p>Neuss, N.; Neuss, M. N. The Alkaloids: Chemistry and Pharmacology. Alkaloids Chem. Pharmacol. 1990, 37, 229-240. <a href="https://doi.org/10.1016/s0099-9598(08)60097-8">https://doi.org/10.1016/s0099-9598(08)60097-8</a>.&#160;<a href="#fnref:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:4">
<p>Cannon, J. S.; Overman, L. E. Is There No End to the Total Syntheses of Strychnine? Lessons Learned in Strategy and Tactics in Total Synthesis. Angew. Chem. Int. Ed. 2012, 51, 4288-4311. <a href="https://doi.org/10.1002/anie.201107385">https://doi.org/10.1002/anie.201107385</a>.&#160;<a href="#fnref:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:5">
<p>Feling, R. H.; Buchanan, G. O.; Mincer, T. J.; Kauffman, C. A.; Jensen, P. R.; Fenical, W. Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus Salinospora. Angew. Chem. Int. Ed. 2003, 42, 355-357. <a href="https://doi.org/10.1002/anie.200390115">https://doi.org/10.1002/anie.200390115</a>.&#160;<a href="#fnref:5" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:6">
<p>Asami, Y.; Kakeya, H.; Onose, R.; Yoshida, A.; Matsuzaki, H.; Osada, H. Azaspirene: A Novel Angiogenesis Inhibitor Containing a 1-Oxa-7-Azaspiro[4.4]Non-2-Ene-4,6-Dione Skeleton Produced by the Fungus Neosartorya Sp. Org. Lett. 2002, 4, 2845-2848. <a href="https://doi.org/10.1021/ol020104+">https://doi.org/10.1021/ol020104+</a>.&#160;<a href="#fnref:6" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:7">
<p>Fujiwara, R.; Haag, M.; Schaeffeler, E.; Nies, A. T.; Zanger, U. M.; Schwab, M. Systemic Regulation of Bilirubin Homeostasis: Potential Benefits of Hyperbilirubinemia. Hepatology 2018, 67, 1609-1619. <a href="https://doi.org/10.1002/hep.29599">https://doi.org/10.1002/hep.29599</a>.&#160;<a href="#fnref:7" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:8">
<p>Njardarson, J. T. Top 200 Small Molecule Drugs by Sales in 2018; 2018. <a href="https://njardarson.lab.arizona.edu/content/top-pharmaceuticals-poster">https://njardarson.lab.arizona.edu/content/top-pharmaceuticals-poster</a>.&#160;<a href="#fnref:8" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:9">
<p>Caruano, J.; Muccioli, G. G.; Robiette, R. Biologically Active γ-Lactams: Synthesis and Natural Sources. Org. Biomol. Chem. 2016, 14, 10134-10156. <a href="https://doi.org/10.1039/c6ob01349j">https://doi.org/10.1039/c6ob01349j</a>.&#160;<a href="#fnref:9" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:10">
<p>Dömling, A.; Wang, W.; Wang, K. Chemistry and Biology Of Multicomponent Reactions. Chem. Rev. 2012, 112, 3083-3135. <a href="https://doi.org/10.1021/cr100233r">https://doi.org/10.1021/cr100233r</a>.&#160;<a href="#fnref:10" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:11">
<p>Zhi, S.; Ma, X.; Zhang, W. Consecutive Multicomponent Reactions for the Synthesis of Complex Molecules. Org. Biomol. Chem. 2019, 17, 7632-7650. <a href="https://doi.org/10.1039/c9ob00772e">https://doi.org/10.1039/c9ob00772e</a>.&#160;<a href="#fnref:11" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:12">
<p>Layer, R. W. The Chemistry of Imines. Chem. Rev. 1963, 63, 489-510. <a href="https://doi.org/10.1021/cr60225a003">https://doi.org/10.1021/cr60225a003</a>.&#160;<a href="#fnref:12" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:13">
<p>Li, C.-J.; Trost, B. M. Green Chemistry for Chemical Synthesis. Proc. Natl. Acad. Sci. 2008, 105, 13197-13202. <a href="https://doi.org/10.1073/pnas.0804348105">https://doi.org/10.1073/pnas.0804348105</a>.&#160;<a href="#fnref:13" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:14">
<p>Sun, A. W.; Lackner, S.; Stoltz, B. M. Modularity: Adding New Dimensions to Total Synthesis. Trends Chem. 2019. <a href="https://doi.org/10.1016/j.trechm.2019.05.008">https://doi.org/10.1016/j.trechm.2019.05.008</a>.&#160;<a href="#fnref:14" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:15">
<p>(a) Gein, V. L.; Kasimova, N. N.; Potemkin, K. D. Simple Three-Component Synthesis of 4-Acyl-1-(2-Aminoethyl)-5-Aryl-3-Hydroxy-2,5-Dihydropyrrol-2(1H)-Ones. Russ. J. Gen. Chem. 2002, 72, 1150-1151. <a href="https://doi.org/10.1023/a:1020783623210;">https://doi.org/10.1023/a:1020783623210;</a> (b) Gein, V. L.; Odegova, T. F.; Korol&rsquo;, A. N.; Varkentin, L. I.; Bobyleva, A. A.; Gein, L. F.; Vakhrin, M. I. Synthesis and Antibacterial Activity of 5-Aryl-4-Acyl-3-Hydroxy-1-(2-Hydroxyethyl)-3-Pyrrolin-2-Ones. Pharm. Chem. J. 2014, 47, 536-538. <a href="https://doi.org/10.1007/s11094-014-0999-5;">https://doi.org/10.1007/s11094-014-0999-5;</a> (c) Gein, V. L.; Vychegzhanina, V. N.; Levandovskaya, E. B.; Syropyatov, B. Y.; Vakhrin, M. I.; Voronina, E. V.; Danilova, N. V. Synthesis and Antibacterial and Analgesic Activity of 5-Aryl-4-Acyl-3-Hydroxy-1(2,2-Dimethoxyethyl)-3-Pyrrolin-2-Ones. Pharm. Chem. J. 2010, 44, 370-373. <a href="https://doi.org/10.1007/s11094-010-0470-1;">https://doi.org/10.1007/s11094-010-0470-1;</a> (d) Gein, V. L.; Kasimova, N. N.; Voronina, É. V.; Gein, L. F. Synthesis and Antimicrobial Activity of 5-Aryl-4-Acyl-1-(N,N-Dimethylaminoethyl)-3-Hydroxy-3-Pyrrolin-2-Ones. Pharm. Chem. J. 2001, 35, 151-154. <a href="https://doi.org/10.1023/a:1010457912881;">https://doi.org/10.1023/a:1010457912881;</a> (e) Gein, V. L.; Buldakova, E. A.; Korol, A. N.; Veikhman, G. A.; Dmitriev, M. V. Synthesis of 5-Aryl-4-Aroyl-3-Hydroxy-1-Cyanomethyl-3-Pyrrolin-2-Ones. Russ. J. Gen. Chem. 2018, 88, 908-911. <a href="https://doi.org/10.1134/s1070363218050110;">https://doi.org/10.1134/s1070363218050110;</a> (f) Gein, V. L.; Kasimova, N. N.; Aliev, Z. G.; Vakhrin, M. I. Three-Component Reaction of Methyl 2,4-Dioxo-4-Phenylbutanoate and Methyl 2,4-Dioxopentanoate with Aromatic Aldehydes and Propane-1,2-Diamine and Chemical Properties of the Products. Russ. J. Org. Chem. 2010, 46, 875-883. <a href="https://doi.org/10.1134/s1070428010060163">https://doi.org/10.1134/s1070428010060163</a>.&#160;<a href="#fnref:15" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:16">
<p>Reddy, T. R. K.; Li, C.; Guo, X.; Myrvang, H. K.; Fischer, P. M.; Dekker, L. V. Design, Synthesis, and Structure-Activity Relationship Exploration of 1-Substituted 4-Aroyl-3-Hydroxy-5-Phenyl-1H-Pyrrol-2(5H)-One Analogues as Inhibitors of the Annexin A2-S100A10 Protein Interaction. J. Med. Chem. 2011, 54, 2080-2094. <a href="https://doi.org/10.1021/jm101212e">https://doi.org/10.1021/jm101212e</a>.&#160;<a href="#fnref:16" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:17">
<p>Ma, K.; Wang, P.; Fu, W.; Wan, X.; Zhou, L.; Chu, Y.; Ye, D. Rational Design of 2-Pyrrolinones as Inhibitors of HIV-1 Integrase. Bioorg. Med. Chem. Lett. 2011, 21, 6724-6727. <a href="https://doi.org/10.1016/j.bmcl.2011.09.054">https://doi.org/10.1016/j.bmcl.2011.09.054</a>.&#160;<a href="#fnref:17" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:18">
<p>(a) Morozova, A. D.; Muravyova, E. A.; Shishkina, S. V.; Sysoiev, D.; Glasnov, T.; Musatov, V. I.; Desenko, S. M.; Chebanov, V. A. Features of 3-Amino-5-Methylisoxazole in Heterocyclizations Involving Pyruvic Acids. Chem. Heterocyc. Compd. 2019, 55, 78-89. <a href="https://doi.org/10.1007/s10593-019-02422-8;">https://doi.org/10.1007/s10593-019-02422-8;</a> (b) Sakhno, Y. I.; Desenko, S. M.; Shishkina, S. V.; Shishkin, O. V.; Sysoyev, D. O.; Groth, U.; Kappe, C. O.; Chebanov, V. A. Multicomponent Cyclocondensation Reactions of Aminoazoles, Arylpyruvic Acids and Aldehydes with Controlled Chemoselectivity. Tetrahedron 2008, 64, 11041-11049. <a href="https://doi.org/10.1016/j.tet.2008.09.089;">https://doi.org/10.1016/j.tet.2008.09.089;</a> (c) Murlykina, M. V.; Sakhno, Y. I.; Desenko, S. M.; Shishkina, S. V.; Shishkin, O. V.; Sysoiev, D. O.; Kornet, M. N.; Schols, D.; Goeman, J. L.; Eycken, J. V. der; et al. Study of the Chemoselectivity of Multicomponent Heterocyclizations Involving 3-Amino-1,2,4-Triazole and Pyruvic Acids as Key Reagents, and Biological Activity of the Reaction Products. Eur. J. Org. Chem. 2015, 2015, 4481-4492. <a href="https://doi.org/10.1002/ejoc.201500469">https://doi.org/10.1002/ejoc.201500469</a>.&#160;<a href="#fnref:18" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:19">
<p>Tye, H.; Whittaker, M. Use of a Design of Experiments Approach for the Optimisation of a Microwave Assisted Ugi Reaction. Org. Biomol. Chem. 2004, 2, 813. <a href="https://doi.org/10.1039/b400298a">https://doi.org/10.1039/b400298a</a>.&#160;<a href="#fnref:19" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:20">
<p>Ahankar, H.; Ramazani, A.; Ślepokura, K.; Lis, T.; Joo, S. W. Synthesis of Pyrrolidinone Derivatives from Aniline, an Aldehyde and Diethyl Acetylenedicarboxylate in an Ethanolic Citric Acid Solution under Ultrasound Irradiation. Green Chem. 2016, 18, 3582-3593. <a href="https://doi.org/10.1039/c6gc00157b">https://doi.org/10.1039/c6gc00157b</a>.&#160;<a href="#fnref:20" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:21">
<p>Yavari, I.; Souri, S. Synthesis of Functionalized 5-Oxo-2,5-Dihydro-1 H -Pyrroles from Primary Alkylamines, Oxalyl Chloride, and Dimethyl Acetylenedicarboxylate. Synlett 2008, 2008, 1208-1210. <a href="https://doi.org/10.1055/s-2008-1072657">https://doi.org/10.1055/s-2008-1072657</a>.&#160;<a href="#fnref:21" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:22">
<p>(a) Cusumano, A. Q.; Pierce, J. G. 3-Hydroxy-1,5-Dihydro-2H-Pyrrol-2-Ones as Novel Antibacterial Scaffolds against Methicillin-Resistant Staphylococcus Aureus. Bioorg. Med. Chem. Lett. 2018, 28, 2732-2735. <a href="https://doi.org/10.1016/j.bmcl.2018.02.047;">https://doi.org/10.1016/j.bmcl.2018.02.047;</a> (b) Cusumano, A. Q.; Boudreau, M. W.; Pierce, J. G. Direct Access to Highly Functionalized Heterocycles through the Condensation of Cyclic Imines and α-Oxoesters. J. Org. Chem. 2017, 82, 13714-13721. <a href="https://doi.org/10.1021/acs.joc.7b02572;">https://doi.org/10.1021/acs.joc.7b02572;</a> (c) Shymanska, N. V.; Pierce, J. G. Stereoselective Synthesis of Quaternary Pyrrolidine-2,3-Diones and β-Amino Acids. Org. Lett. 2017, 19, 2961-2964. <a href="https://doi.org/10.1021/acs.orglett.7b01185;">https://doi.org/10.1021/acs.orglett.7b01185;</a> (d) Massaro, N. P.; Pierce, J. G. Stereoselective, Multicomponent Approach to Quaternary Substituted Hydroindole Scaffolds. Org. Lett. 2020, 22, 5079-5084. <a href="https://doi.org/10.1021/acs.orglett.0c01650;">https://doi.org/10.1021/acs.orglett.0c01650;</a> (e) Massaro, N. P.; Pierce, J. G. Rapid synthesis of the core scaffold of crinane and haemanthamine through a multi-component approach. Tetrahedron Lett. 2021, 75, 153201. <a href="https://doi.org/10.1016/j.tetlet.2021.153201">https://doi.org/10.1016/j.tetlet.2021.153201</a>.&#160;<a href="#fnref:22" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
</ol>
</div>

  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
<nav class="paginav">
  <a class="prev" href="//localhost:1313/posts/orgsyn023/">
    <span class="title">« Prev</span>
    <br>
    <span>OrgSyn023</span>
  </a>
  <a class="next" href="//localhost:1313/posts/orgsyn021/">
    <span class="title">Next »</span>
    <br>
    <span>OrgSyn021</span>
  </a>
</nav>

  </footer>
</article>
    </main>
    
<footer class="footer">
        <span>&copy; 2025 <a href="//localhost:1313/">OrgSyn</a></span> · 

    <span>
        Powered by
        <a href="https://gohugo.io/" rel="noopener noreferrer" target="_blank">Hugo</a> &
        <a href="https://github.com/adityatelange/hugo-PaperMod/" rel="noopener" target="_blank">PaperMod</a>
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
